EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
Monthly Return of Equity Issuer on Movements in Securities
INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024
Monthly Return of Equity Issuer on Movements in Securities
DISCLOSEABLE TRANSACTION PURCHASE OF STRUCTURED DEPOSIT
VOLUNTARY ANNOUNCEMENT POSITIVE PRELIMINARY PHASE I CLINICAL RESULTS FOR PROTEIN-BASED PNEUMOCOCCAL VACCINE
VOLUNTARY ANNOUNCEMENT HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE, FREEZE-DRIED OBTAINS CLINICAL TRIAL APPROVAL
2023 Annual Report
2023 Environmental, Social and Governance & Corporate Social Responsibility Report
FIRST QUARTERLY REPORT FOR THE THREE MONTHS ENDED MARCH 31, 2024
NOTICE OF BOARD MEETING
1
2
3
4
5
6
44